DTB select: Dexamethasone for COVID-19: preliminary findings

Summary and context is provided on preliminary findings from RECOVERY study showing that for patients hospitalised with COVID-19, dexamethasone 6 mg daily for 10 days reduced 28-day mortality among those receiving invasive mechanical ventilation or oxygen at randomisation.


Drug and Therapeutics Bulletin